YDR514C Antibody

What is YDR514C and why are antibodies against it important for research?

YDR514C is a gene in Saccharomyces cerevisiae (baker's yeast) that encodes a protein involved in cellular processes. Antibodies against this protein are critical research tools that enable detection, quantification, and functional characterization of the YDR514C protein in various experimental contexts. These antibodies facilitate studies on protein expression, localization, interactions, and modifications, providing insights into YDR514C's biological functions. While antibody selection might seem straightforward, the YCharOS initiative has demonstrated that antibody performance can vary significantly across applications, highlighting the importance of proper validation before experimental use . Selecting appropriate antibodies is foundational to obtaining reliable, reproducible results in YDR514C-related research.

How should I validate a YDR514C antibody before use in my experiments?

Validation of any research antibody, including those targeting YDR514C, should involve multiple complementary approaches:

• Genetic controls validation: Use wild-type yeast strains alongside YDR514C knockout strains to confirm antibody specificity. The absence of signal in knockout samples strongly indicates specificity for the target protein .

• Multiple application testing: Verify antibody performance in your specific application (Western blot, immunoprecipitation, or immunofluorescence) rather than assuming cross-application reliability .

• Orthogonal validation: Compare antibody detection with other methods of protein detection or quantification, such as mass spectrometry or fluorescent protein tagging .

• Literature verification: Review published data using the same antibody, but be cautious as YCharOS data indicates that many published results may have used inadequately validated antibodies .

YCharOS data suggests that antibodies with vendor-provided genetic control data typically demonstrate better performance, making this an important selection criterion .

What are the most reliable applications for YDR514C antibody use?

Based on antibody characterization data from YCharOS (though not specific to YDR514C), Western blotting generally shows better antibody performance compared to immunofluorescence or immunoprecipitation . For YDR514C research:

• Western blot: Typically the most reliable application for detecting YDR514C protein, allowing visualization of protein size and relative abundance. The best antibodies show strong bands only in wild-type samples and no bands in knockout controls .

• Co-immunoprecipitation: Can be used to study protein-protein interactions involving YDR514C, though selectivity should be independently verified as good Western blot performance doesn't guarantee good immunoprecipitation performance .

• Immunofluorescence: Generally shows poorer antibody performance across proteins studied by YCharOS, suggesting extra validation is critical before using YDR514C antibodies for localization studies .

When selecting applications, consider that monoclonal recombinant antibodies often demonstrate superior performance compared to polyclonal antibodies, particularly in terms of specificity and reproducibility .

How can I distinguish between specific and non-specific binding in YDR514C antibody applications?

Distinguishing specific from non-specific binding requires rigorous controls and validation strategies:

• Genetic knockout controls: The gold standard for specificity validation involves comparing signal between wild-type and YDR514C knockout strains. Complete signal elimination in knockout samples indicates high specificity .

• Band pattern analysis: In Western blots, examine whether multiple bands appear in wild-type samples. While these might represent protein isoforms, post-translational modifications, or multimers of YDR514C, they could also indicate non-specific binding .

• Competition assays: Pre-incubate the antibody with purified YDR514C protein before application. Specific binding should be competitively inhibited, while non-specific binding will remain .

• Sequential epitope analysis: For polyclonal antibodies, consider analyzing which epitopes are recognized using peptide arrays or deletion mutants to distinguish specific from non-specific interactions .

• Cross-reactivity testing: Test antibody against closely related proteins to ensure it doesn't cross-react with structural homologs of YDR514C .

YCharOS data reveals that antibodies demonstrating selective binding in Western blot do not necessarily exhibit similar selectivity in other applications, emphasizing application-specific validation .

How do post-translational modifications of YDR514C affect antibody recognition?

Post-translational modifications (PTMs) can significantly impact antibody-epitope interactions:

• Phosphorylation masking: If YDR514C undergoes phosphorylation (particularly likely if involved in signaling pathways similar to Snf1), this may mask epitopes recognized by certain antibodies. Consider using phosphatase treatment before antibody application to determine if phosphorylation affects recognition .

• Ubiquitination interference: YDR514C may undergo ubiquitination similar to other yeast proteins. This can alter epitope accessibility or create steric hindrance for antibody binding. Comparison of recognition patterns under different cellular conditions may reveal modification-dependent binding .

• PTM-specific antibodies: Consider whether you need antibodies that specifically recognize modified forms of YDR514C. These must be separately validated using appropriate controls, such as samples treated with modification-removing enzymes .

• Multiple band patterns: In Western blot analysis, multiple bands may represent differently modified forms of YDR514C rather than non-specific binding. Careful molecular weight analysis and treatment with modification-removing enzymes can help distinguish these possibilities .

For accurate interpretation of results, always consider the cellular context and conditions that might alter YDR514C's modification state and subsequently affect antibody recognition .

What strategies can overcome poor YDR514C antibody performance in immunofluorescence studies?

Immunofluorescence generally shows poorer antibody performance than Western blotting, according to YCharOS data . To enhance YDR514C detection in immunofluorescence:

• Fixation optimization: Test multiple fixation methods (paraformaldehyde, methanol, acetone) as epitope accessibility can vary dramatically with different fixatives.

• Antigen retrieval techniques: Apply heat-induced or enzymatic antigen retrieval methods to expose epitopes that might be masked during fixation.

• Signal amplification systems: Implement tyramide signal amplification or other amplification strategies to enhance weak but specific signals.

• Alternative antibody selection: Consider recombinant monoclonal antibodies, which YCharOS data suggests may perform better than polyclonals in immunofluorescence applications .

• Genetic controls implementation: Always include YDR514C knockout strains processed identically to experimental samples to definitively distinguish specific from non-specific staining .

• Tagged protein comparison: Generate strains expressing fluorescently-tagged YDR514C to compare localization patterns with immunofluorescence results, providing an orthogonal validation method.

Remember that YCharOS found immunofluorescence performance was globally poor even for antibodies with strong Western blot performance, suggesting inherent limitations to this application that may require multiple validation approaches .

What are the optimal protocols for YDR514C detection by Western blotting?

Optimal Western blotting protocols for YDR514C detection require careful consideration of sample preparation, antibody application, and controls:

• Sample preparation:

  • Extract proteins using methods that preserve YDR514C integrity (e.g., alkaline lysis with NaOH/β-ME followed by TCA precipitation for yeast cells)

  • Include protease and phosphatase inhibitors to prevent degradation and modification changes

  • Consider DNase I treatment if DNA contamination might affect sample migration

• Gel separation and transfer:

  • Select appropriate acrylamide percentage based on YDR514C's molecular weight

  • Use wet transfer methods for more complete transfer of larger proteins

  • Consider PVDF membranes for higher protein binding capacity

• Antibody application:

  • Optimize primary antibody concentrations (typically 1:500-1:5000 dilution)

  • Use overnight incubation at 4°C to improve signal-to-noise ratio

  • Include 5% BSA or milk in blocking and antibody solutions to reduce background

• Controls:

  • Always run wild-type alongside YDR514C knockout lysates

  • Include loading controls (e.g., anti-Pgk1) to normalize protein amounts

  • Consider using tagged YDR514C as a positive control if available

• Detection optimization:

  • Choose detection chemistry (ECL, fluorescence) based on sensitivity requirements

  • Adjust exposure times to avoid signal saturation for accurate quantification

Always validate the antibody's performance using genetic controls before experimental application, as YCharOS data indicates this is strongly correlated with antibody reliability .

How can I optimize co-immunoprecipitation protocols using YDR514C antibodies?

Successful co-immunoprecipitation (Co-IP) of YDR514C protein complexes requires careful optimization:

• Buffer composition:

  • Use buffers containing appropriate salt concentration (e.g., IP300 with 300mM NaCl)

  • Include detergents like 0.1% Triton X-100 to solubilize membrane-associated proteins while preserving interactions

  • Add glycerol (10%) to stabilize protein complexes

  • Include protease inhibitors and phosphatase inhibitors if studying phosphorylation

• Pre-clearing and controls:

  • Pre-clear lysates with beads alone to reduce non-specific binding

  • Include DNase I treatment (200 units for 1h) if DNA-mediated interactions might occur

  • Always process wild-type and knockout samples in parallel

  • Include a non-specific antibody control (same isotype/species)

• Antibody selection and coupling:

  • Test multiple antibodies as Co-IP performance doesn't necessarily correlate with Western blot performance

  • Consider directly conjugating antibodies to beads to reduce background from IgG bands

  • For recombinant tagged YDR514C, consider anti-tag antibodies (FLAG, myc) which often show high specificity

• Washing and elution conditions:

  • Optimize wash stringency based on interaction strength (more washes with lower salt vs. fewer washes with higher salt)

  • Test various elution methods (SDS, low pH, peptide competition) depending on downstream applications

• Detection methods:

  • Analyze both the immunoprecipitated YDR514C and co-precipitated partners

  • Consider mass spectrometry for unbiased identification of interaction partners

Remember that YCharOS data indicates immunoprecipitation performance is generally lower than Western blot performance, emphasizing the need for robust controls and optimization .

What methods can differentiate between specific antibody binding and off-target effects in YDR514C studies?

Differentiating specific from non-specific binding is crucial for accurate interpretation of YDR514C antibody data:

• Genetic control validations:

  • Compare wild-type to YDR514C knockout samples in parallel for all applications

  • Use strains with varying YDR514C expression levels (e.g., promoter modifications) to observe signal correlation with expression

• Epitope blocking experiments:

  • Pre-incubate antibody with purified YDR514C protein or peptides corresponding to the epitope

  • Specific binding should be competitively inhibited while non-specific binding remains

• Multiple antibody verification:

  • Use different antibodies targeting distinct YDR514C epitopes

  • Consistent results across antibodies increase confidence in specificity

• Orthogonal detection methods:

  • Compare antibody-based detection with mass spectrometry or RNA-expression correlation

  • Use fluorescent protein-tagged YDR514C as an alternative detection method

• Bioinformatic analysis:

  • Predict potential cross-reactive proteins through sequence and structural homology

  • Test antibody against these predicted cross-reactive proteins

• Signal reduction through RNAi or CRISPR:

  • Demonstrate signal reduction through partial YDR514C knockdown

  • Particularly valuable in systems where complete knockout is unavailable

YCharOS data emphasizes that genetic control validation is the strongest predictor of antibody performance, showing clear correlation with reliable results across applications .

How should I interpret multiple band patterns in Western blots using YDR514C antibodies?

Multiple bands in Western blots using YDR514C antibodies can have several interpretations requiring careful analysis:

• Potential explanations for multiple bands:

  • Protein isoforms from alternative splicing (though less common in yeast)

  • Post-translational modifications (phosphorylation, ubiquitination)

  • Proteolytic fragments due to sample processing

  • Non-specific binding to other proteins

  • Multimeric forms of YDR514C (dimers, trimers)

• Verification strategies:

  • Compare band patterns between wild-type and knockout samples; bands present in both represent non-specific binding

  • Examine whether band sizes match predicted modifications (e.g., ~8kDa increase for ubiquitination)

  • Treat samples with phosphatases or deubiquitinases to determine if bands collapse to a single form

  • Compare patterns across different sample preparation methods to identify degradation products

• Molecular weight analysis:

  • Calculate precise molecular weights using standard curves

  • Compare observed weights with predicted weights for known modifications

  • Verify if truncated forms match known domains of YDR514C

• Antibody specificity consideration:

  • YCharOS data indicates that even antibodies showing multiple wild-type bands but no knockout bands can be considered selective, as these may represent different forms of the target protein

When interpreting results, remember that YCharOS found multiple bands in wild-type samples often represent true protein variants rather than non-specific binding, especially when these bands are absent in knockout samples .

What factors might contribute to inconsistent results with YDR514C antibodies across experiments?

Inconsistent results with YDR514C antibodies can stem from multiple factors requiring systematic troubleshooting:

• Antibody storage and handling:

  • Repeated freeze-thaw cycles can degrade antibody quality

  • Improper storage temperature or contamination

  • Lot-to-lot variability in commercial antibodies

• Sample preparation variables:

  • Differences in lysis buffers affecting protein solubilization

  • Inconsistent protease inhibitor effectiveness

  • Variable post-translational modification status under different growth conditions

  • Cell density variations affecting YDR514C expression levels

• Experimental condition differences:

  • Variations in blocking reagents affecting background

  • Inconsistent washing stringency between experiments

  • Temperature fluctuations during incubation periods

  • Development time variations in signal detection

• Biological variables:

  • Growth phase differences in yeast cultures affecting YDR514C expression

  • Media composition changes influencing protein modification status

  • Genetic drift in laboratory strains over time

• Technical considerations:

  • Western blot transfer efficiency variations

  • Differences in detection system sensitivity between experiments

  • Changes in equipment performance over time

YCharOS findings highlight that antibody performance can vary significantly even under standardized conditions, emphasizing the importance of consistent protocols and robust controls in every experiment .

How can I resolve discrepancies between different detection methods for YDR514C protein?

Resolving discrepancies between different detection methods requires systematic analysis of each method's strengths and limitations:

• Method-specific considerations:

  • Western blot: Detects denatured protein, may miss native conformational epitopes

  • Immunofluorescence: Preserves spatial information but may have fixation artifacts

  • Immunoprecipitation: Maintains some protein interactions but may lose transient ones

  • Mass spectrometry: Provides unbiased detection but has sensitivity limitations

• Epitope accessibility analysis:

  • Different methods expose different epitopes (denatured vs. native)

  • Post-translational modifications may differentially affect epitope recognition across methods

  • Protein-protein interactions may mask epitopes in certain applications

• Control implementation:

  • Use tagged YDR514C proteins detectable by anti-tag antibodies as internal controls

  • Compare results with orthogonal methods like fluorescent protein tagging

  • Include samples with known YDR514C expression levels as calibration standards

• Systematic validation approach:

  • Test multiple antibodies recognizing different epitopes

  • Examine correlation between RNA expression and protein detection

  • Validate with genetic approaches (knockdown, knockout, overexpression)

• Technical optimization:

  • Adjust fixation conditions for immunofluorescence (different fixatives expose different epitopes)

  • Modify lysis conditions for Western blot and immunoprecipitation

  • Alter incubation times and temperatures to optimize each method

YCharOS data indicates that antibody performance rarely translates across applications, explaining why discrepancies between methods are common and emphasizing the need for application-specific validation .

How can YDR514C antibodies be used to study protein-protein interactions in complex cellular environments?

Studying YDR514C protein interactions requires sophisticated approaches leveraging antibody specificity:

• Co-immunoprecipitation strategies:

  • Standard Co-IP with YDR514C antibodies followed by mass spectrometry to identify interaction partners

  • Reciprocal Co-IP validating interactions from both directions

  • Sequential Co-IP (tandem purification) for detecting components of multi-protein complexes

  • Crosslinking before Co-IP to capture transient interactions

• Proximity labeling techniques:

  • BioID or TurboID fusion to YDR514C to biotinylate proximal proteins

  • APEX2 fusion for electron microscopy visualization of interaction environments

  • Using antibodies to verify proximity labeling results by conventional methods

• In situ visualization of interactions:

  • Proximity Ligation Assay (PLA) using YDR514C antibody paired with antibodies against suspected interaction partners

  • FRET analysis with fluorescently-labeled antibodies to detect protein proximity

  • Immunofluorescence co-localization studies with quantitative overlap analysis

• Functional interaction validation:

  • Mutation of potential interaction domains followed by Co-IP to validate specific binding regions

  • Competition assays with peptides corresponding to interaction interfaces

  • Correlation of interaction strength with functional outputs

• Dynamic interaction studies:

  • Time-course analyses after cellular stimulation or stress

  • Comparing interactions across different growth conditions or cell cycle stages

When designing interaction studies, consider that YCharOS data shows immunoprecipitation selectivity cannot be inferred from Western blot performance, necessitating specific validation of antibodies for interaction studies .

What approaches can detect post-translational modifications of YDR514C using specific antibodies?

Detecting post-translational modifications (PTMs) of YDR514C requires specialized antibody-based approaches:

• Modification-specific antibody selection:

  • Use antibodies specifically recognizing phosphorylated, ubiquitinated, or otherwise modified YDR514C

  • Validate modification-specific antibodies using treatment with modifying or demodifying enzymes

  • Consider generating custom modification-specific antibodies if commercial options are unavailable

• Combined immunoprecipitation approaches:

  • Immunoprecipitate YDR514C first, then probe with modification-specific antibodies

  • Immunoprecipitate with modification-specific antibodies, then probe for YDR514C

  • Use tandem purification with both antibody types for highest specificity

• In-gel detection strategies:

  • Utilize mobility shift assays to detect modifications that alter protein migration

  • Apply Phos-tag gels for enhanced separation of phosphorylated forms

  • Use 2D gel electrophoresis to separate YDR514C forms by charge and size

• Mass spectrometry validation:

  • Immunoprecipitate YDR514C and analyze by mass spectrometry to map modification sites

  • Perform parallel reaction monitoring (PRM) for targeted quantification of specific modified peptides

  • Compare modification patterns across different conditions

• Functional correlation studies:

  • Associate modification status with functional outputs through genetic manipulation

  • Study modification dynamics during cellular responses or stress conditions

  • Compare modification patterns across yeast mutants affecting modification pathways

When studying phosphorylation specifically, techniques similar to those used for Snf1 T210 phosphorylation analysis can be adapted, including phospho-specific antibodies and careful sample preparation to preserve modification status .

How can YDR514C antibodies be integrated with genomic and proteomic approaches for systems biology studies?

Integrating YDR514C antibody-based methods with multi-omic approaches enables comprehensive systems biology studies:

• ChIP-seq and related techniques:

  • Chromatin immunoprecipitation with YDR514C antibodies to map genomic binding sites

  • CUT&RUN or CUT&Tag for higher resolution genomic binding profiles

  • ChIP-MS to identify co-factors at genomic locations

• Proteome-wide interaction mapping:

  • Immunoprecipitation coupled with mass spectrometry (IP-MS) to identify the YDR514C interactome

  • BioID or proximity labeling followed by mass spectrometry for spatial interaction mapping

  • Correlation of interactome changes with transcriptomic alterations

• Multi-dimensional data integration:

  • Correlate YDR514C binding patterns with transcriptional changes

  • Associate post-translational modifications with interaction network alterations

  • Map YDR514C-dependent processes across cellular compartments and conditions

• Spatial proteomics applications:

  • Combine immunofluorescence data with proteome-wide localization studies

  • Correlate YDR514C localization with organelle-specific proteomes

  • Track YDR514C redistribution during cellular responses

• Quantitative biology approaches:

  • Use antibodies for absolute quantification of YDR514C in different cellular compartments

  • Measure stoichiometry of YDR514C within protein complexes

  • Develop mathematical models incorporating YDR514C concentration and modification state

• Temporal dynamics studies:

  • Track YDR514C expression, localization, and modification changes across time

  • Correlate with transcriptomic and metabolomic temporal profiles

  • Develop predictive models of YDR514C function in cellular networks

When designing integrated studies, consider that many antibodies may not perform optimally across all applications, necessitating application-specific validation as demonstrated by YCharOS initiatives .

What emerging technologies will improve YDR514C antibody reliability and application range?

Emerging technologies promise to enhance YDR514C antibody reliability and expand applications:

• Next-generation recombinant antibodies:

  • Fully human recombinant antibodies developed through phage display technologies offer improved specificity and reduced batch variation

  • Site-specific antibody engineering to enhance performance in specific applications

  • Development of nanobodies and single-domain antibodies for improved access to sterically hindered epitopes

• Validation technologies:

  • Expanded knockout cell line resources for comprehensive validation

  • High-throughput epitope mapping technologies to better characterize binding sites

  • Standardized multi-application testing platforms similar to YCharOS initiatives

• Enhanced detection systems:

  • Super-resolution microscopy compatible antibody conjugates

  • Multiplexed antibody detection systems for simultaneous analysis of multiple targets

  • Mass cytometry applications for single-cell protein analysis

• Antibody alternatives and complements:

  • Aptamers as alternatives to traditional antibodies

  • Designed ankyrin repeat proteins (DARPins) for target recognition

  • CRISPR-based tagging systems for endogenous protein labeling

• Integrated validation ecosystems:

  • Expansion of collaborative initiatives like YCharOS to cover more proteins including yeast proteins

  • Development of standardized reporting formats for antibody validation

  • Implementation of machine learning approaches to predict antibody performance

As these technologies develop, researchers should remain attentive to validation requirements, as YCharOS data demonstrates that even with technological advances, comprehensive validation remains essential for reliable antibody applications .

How can I contribute to community resources for YDR514C antibody validation?

Contributing to community resources for antibody validation benefits all researchers and advances scientific reproducibility:

• Data sharing practices:

  • Publish detailed validation data for YDR514C antibodies in supplementary materials

  • Submit antibody validation data to repositories like Antibodypedia or the Antibody Registry

  • Contribute to collaborative initiatives similar to YCharOS for yeast proteins

• Validation standardization:

  • Implement and promote standardized validation protocols

  • Adopt the five pillars of antibody validation proposed by international working groups

  • Use consistent reporting formats for validation experiments

• Negative result reporting:

  • Share information about antibodies that failed validation tests

  • Document specificity issues and cross-reactivity observations

  • Report application-specific limitations for otherwise functional antibodies

• Open science practices:

  • Provide detailed methodological information including exact buffer compositions

  • Share raw data from validation experiments in public repositories

  • Contribute to community-driven antibody rating systems

• Collaborative engagement:

  • Participate in multi-laboratory validation studies

  • Engage with vendors to improve antibody characterization

  • Join or initiate antibody working groups in your research community

By contributing validation data, researchers help address the "antibody horror show" problem identified in the antibody literature, where inadequate validation leads to irreproducible results and wasted resources .

What key considerations should guide my selection of YDR514C antibodies for new research projects?

When selecting YDR514C antibodies for new research, consider these key factors based on YCharOS findings and antibody research best practices:

• Application-specific validation:

  • Select antibodies specifically validated for your intended application

  • Don't assume cross-application performance, as YCharOS data shows poor correlation across applications

  • Prioritize antibodies with demonstration of performance in your specific experimental system

• Antibody characteristics:

  • Consider recombinant monoclonal antibodies, which YCharOS data suggests often outperform polyclonals

  • Evaluate the specific epitope recognized and its conservation/accessibility in your experimental conditions

  • For certain applications, consider the benefits of different antibody formats (full IgG, Fab fragments, etc.)

• Validation evidence quality:

  • Prioritize antibodies with genetic control validation data (wild-type vs. knockout)

  • Evaluate the comprehensiveness of validation across multiple applications

  • Consider the reputation and validation standards of the antibody provider

• Reproducibility considerations:

  • Select renewable antibody sources (hybridomas, recombinant) rather than limited-supply polyclonals

  • Document lot numbers and request certificate of analysis data

  • Implement internal validation before committing to large-scale experiments

• Technical compatibility:

  • Ensure compatibility with your buffer systems and experimental conditions

  • Consider potential interference from tags or fusion proteins in your system

  • Evaluate secondary detection system compatibility and optimization requirements